TrialAmerican journal of clinical dermatology2022

Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.

Alan Menter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.